Post-Operative Cesarean Section Cosmesis
Launched by WAKE FOREST UNIVERSITY HEALTH SCIENCES · May 8, 2024
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at ways to improve the appearance of the skin after a cesarean delivery (C-section). With many women having C-sections today, researchers want to find the best surgical techniques to help with healing and minimize scarring. They are currently recruiting participants who are scheduled for a C-section and are between the ages of 18 and 44. Eligible women can be of any race and may have had previous pregnancies.
If you choose to participate, you can expect to receive care tailored to your needs during your C-section, and your recovery will be closely monitored. It's important to know that certain conditions may exclude someone from joining the study, such as speaking a language other than English, having specific health issues, or a very high body weight. This trial aims to gather more scientific evidence to support better surgical practices for C-sections, ultimately helping women heal better after surgery.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Age 18-44
- • Any race
- • Any parity
- • Scheduled cesarean section
- • Neuraxial analgesia
- Exclusion Criteria:
- • Non-English Speaking
- • Incarcerated
- • Maternal Connective Tissue Disorder
- • Systemic maternal steroid use
- • Three prior cesarean deliveries
- • Body Mass Index (BMI) \>40
About Wake Forest University Health Sciences
Wake Forest University Health Sciences is a leading academic research institution dedicated to advancing healthcare through innovative clinical trials and translational research. With a strong emphasis on multidisciplinary collaboration, the organization leverages its extensive expertise in medical research, patient care, and education to develop and evaluate new therapies and interventions. Committed to improving patient outcomes and public health, Wake Forest University Health Sciences fosters a dynamic environment for scientific inquiry, engaging in a wide range of clinical studies that address pressing health challenges. Through its rigorous methodologies and ethical standards, the institution aims to contribute significantly to the medical field and enhance the quality of life for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Winston Salem, North Carolina, United States
Patients applied
Trial Officials
Joshua F Nitsche, MD
Principal Investigator
Wake Forest University Health Sciences
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported